Advancing the Line with New Combination Therapies for Malignant Melanoma

Learn about emerging combination strategies for patients with metastatic melanoma, including those with checkpoint inhibitor refractory metastatic melanoma, with this on-demand webcast and downloadable slides from a live Grand Rounds series.

Share

Program Content

Activities

Combination Therapy in Melanoma
Advancing the Line With New Combination Therapies for Malignant Melanoma
Video
Congratulations: You achieved a completion on 04/09/2022

Released: September 12, 2023

Expires: September 11, 2024

Activities

SlidesetCombination Therapy for Melanoma
Advancing the Line With New Combination Therapies for Malignant Melanoma
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 22, 2023

Faculty

cover img faculity

C. Lance Cowey, MD

Medical Director
Division of Skin Malignancy Research and Treatment Center
Baylor-Sammons Cancer Center
Texas Oncology
Dallas, Texas

cover img faculity

Evan J. Lipson, MD

Associate Professor of Oncology
Melanoma and Cancer Immunology Programs
Bloomberg-Kimmel Institute for Cancer Immunotherapy
Johns Hopkins University School of Medicine
Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland

Provided by

ProCE Banner
ProCE Banner

Jointly provided by USF Health and Rockpointe.

Supporters

Supported by educational grants from Eisai Inc. and Merck Sharp & Dohme LLC.

Eisai Inc.

Merck Sharp & Dohme, LLC